Medium materiality6/10
Piper Sandler Raises Glaukos Price Target to $240 from $195
Why it may matterVerify against the original reporting
Positive analyst revision, tempered by the large post-signal gain.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Piper Sandler raised its GKOS target to $240 from $195. Shares were up 30.96% since the signal and the posted price was $181.43, so the target revision is positive but follows a sharp rally.
- Target raised by $45 to $240; posted price $181.43.
- Shares up 30.96% since signal.
Key facts
- 01
Target: $240
- 02
Posted price: $181.43
- 03
Analyst firm: Piper Sandler
- 04
Analyst: Matt O'Brien
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.